AI chatbots aim to fix overtesting in ovarian cancer screening
NCT ID NCT07503054
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a conversation with an AI can help gynecologists better understand the risks and benefits of ovarian cancer screening. Many doctors overestimate how helpful screening is for average-risk women. The study will involve 350 gynecologists and compare an AI discussion about screening evidence to one about general cancer facts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER SCREENING RECOMMENDATIONS BY GYNECOLOGISTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité - Universitätsmedizin Berlin
Mitte, State of Berlin, 10117, Germany